Next Article in Journal
Raspberry-Like Bismuth Oxychloride on Mesoporous Siliceous Support for Sensitive Electrochemical Stripping Analysis of Cadmium
Previous Article in Journal
Ortho-Nitro Effect on the Diastereoselective Control in Sulfa-Staudinger and Staudinger Cycloadditions
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Nine Different Chemical Species and Action Mechanisms of Pancreatic Lipase Ligands Screened Out from Forsythia suspensa Leaves All at One Time

Institute of Molecular Science, Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Shanxi University, Taiyuan 030006, China
*
Author to whom correspondence should be addressed.
Molecules 2017, 22(5), 795; https://doi.org/10.3390/molecules22050795
Submission received: 30 March 2017 / Revised: 3 May 2017 / Accepted: 10 May 2017 / Published: 12 May 2017
(This article belongs to the Section Natural Products Chemistry)

Abstract

:
It is difficult to screen out as many active components as possible from natural plants all at one time. In this study, subfractions of Forsythia suspensa leaves were firstly prepared; then, their inhibitive abilities on pancreatic lipase were tested; finally, the highest inhibiting subfraction was screened by self-made immobilized pancreatic lipase. Results showed that nine ligands, including eight inhibitors and one promotor, were screened out all at one time. They were three flavonoids (rutin, IC50: 149 ± 6.0 μmol/L; hesperidin, 52.4 μmol/L; kaempferol-3-O-rutinoside, isolated from F. suspensa leaves for the first time, IC50 notably reached 2.9 ± 0.5 μmol/L), two polyphenols (chlorogenic acid, 3150 ± 120 μmol/L; caffeic acid, 1394 ± 52 μmol/L), two lignans (phillyrin, promoter; arctigenin, 2129 ± 10.5 μmol/L), and two phenethyl alcohol (forsythiaside A, 2155 ± 8.5 μmol/L; its isomer). Their action mechanisms included competitive inhibition, competitive promotion, noncompetitive inhibition, and uncompetitive inhibition. In sum, using the appropriate methods, more active ingredients can be simply and quickly screened out all at one time from a complex natural product system. In addition, F. suspensa leaves contain numerous inhibitors of pancreatic lipase.

Graphical Abstract

1. Introduction

Obesity has become one of the greatest threats to human health in this century. It is recognized as the largest global chronic disease by WHO [1,2]. At least 3,400,000 adults die each year as a result of being overweight or obese [3,4]. Because pancreatic lipase (PL) can decompose 50–70% of fat, developing its inhibitor as an anti-obesity drug is preferred. Orlistat is a type of long-term PL inhibitor found and modified from Streptomyces toxytricini and is currently one of the main drugs for treating obesity. However, this drug produces several side effects including fatty diarrhea, stool urgency, fecal incontinence, allergies, and liver function damage [5,6,7].
In recent years, developing safer and more effective PL inhibitors from natural compounds has attracted more and more attention [8,9,10,11], and some new technologies are emerging [12,13]. We also used immobilized enzyme technology to screen PL inhibitors from Polygonum cuspidatum [14].
Forsythia suspensa (Thunb.) Vahl is widely distributed in China, Japan, and Korea. Their fruits have anti-inflammatory, anti-viral, anti-pyretic, anti-liver injury, and other effects [15,16,17,18]. Their leaves are often used for tea. In this study, in order to find out whether F. suspensa tea, like black tea [19], oolong tea [20], and green tea [21], also possess an inhibitory effect on PL, its subfractions were prepared, and their inhibitive ability on PL were detected; then, the highest inhibiting subfraction was screened by self-made immobilized PL.

2. Results and Discussion

2.1. Inhibition of the Subfractions of F. suspensa Leaves on PL

As a positive drug, the inhibition rate of 5 μg/mL orlistat reached 58%, and its success proved the feasibility of the enzyme activity assay. The inhibitory effects of crude extracts and various extract subfractions of F. suspensa leaves on PL at 1500 μg/mL are shown in Table 1. The table shows that the inhibition rate of the remaining parts on PL was the highest and reached 81.48%. Thus, the remaining precipitation of F. suspensa leaves was selected as the screening object of immobilized enzyme.

2.2. Screening of PL Inhibitors in the Remaining Precipitation

The HPLC results are shown in Figure 1. Figure 1A,B shows that 21 absorption peaks occurred in the remaining precipitation. Ten compounds, which may interact with PL, were screened out by the immobilized enzyme (Figure 1C,D).
Among the ten compounds, Compounds 1, 2, 4, 5, 8 and 9 were rutin, phillyrin, chlorogenic acid, caffeic acid, forsythiaside A, and hesperidin respectively by compared with the mixed standard substances (Figure 1E). The undetermined compounds were separated and identified by HPLC-MS/MS; Compounds 6, 7, and 10 were identified as an isomer of forsythiaside A, arctigenin, and kaempferol-3-O-rutinoside, shown in Figure 2 and Table 2. Compound 3 had not been previously identified. The fully identified 8 PL ligands from F. suspensa leaves are shown in Figure 3.

2.3. The Detection of Enzyme Inhibitory Activity and Competition Types of All Inhibitors

Of the eight compounds with identified structures, references [22,23,24,25] have shown the PL inhibitory activities of five compounds, including 4 (chlorogenic acid), 5 (caffeic acid), 1 (rutin), 9 (hesperidin), and 10 (kaempferol-3-O-rutinoside) (their inhibitory abilities were not tested in this study; these references only illustrated the success of this experiment system). The PL inhibitory activities of Compounds 7 (arctigenin), 8 (forsythiaside A), and 2 (phillyrin) were detected. The results are shown in Figure 4. Of these eight compounds, the inhibitory effect of kaempferol-3-O-rutinoside on PL was the strongest, with an IC50 value of 2.9 ± 0.5 μmol/L, followed by hesperidin and rutin, with IC50 values of 52.4 and 149 ± 6.0 μmol/L, respectively. The inhibitory effects of caffeic acid, arctigenin, forsythiaside A, and chlorogenic acid were lower. Interestingly, phillyrin exhibited no inhibitory effect on PL, but showed a promoting effect (see Table 3).
The standard curve of pNP is shown in Figure 5, the inhibition types of the remaining precipitation and the eight compounds were both detected and are shown in Figure 6. Kaempferol-3-O-rutinoside showed non-competitive inhibition. Rutin, hesperidin, and forsythiaside A showed competitive inhibition (the isomer of forsythiaside A might have the same ability). Caffeic acid, chlorogenic acid, and arctigenin exhibited uncompetitive inhibition. Phillyrin was a special compound that showed a competitive promoting effect.
All of the experimental results of the nine ligands are shown in Table 3.

2.4. Discussion

In this study, nine ligands that could interact with PL were screened out all at one time by an immobilized enzyme screening model. The reasons are listed as follows: (1) We chose an immobilized enzyme carrier that has as little adsorption ability as possible to avoid nonspecific adsorption; (2) We closed the remaining carboxyl of the magnetic bead surface via small- and little-absorption-ability compounds; (3) We screened for a higher active subfraction; (4) We chose a suitable eluent and denaturant, and their concentration; (5) We chose a suitable HPLC mobile phase and elution gradient to obtain a smooth baseline and good separation effects; (6) We scanned a full wavelength of the screened sample and then chose suitable HPLC detection wavelengths. Put simply, using these methods can lead to compounds with less nonspecific absorption and with more specific absorption.
In this study, two new PL inhibitors, arctigenin and forsythiaside A, were found. Kaempferol-3-O-rutinoside, which could not be found from F. suspensa before, was screened out for the first time, and its IC50 notably reached 2.9 ± 0.5 μmol/L; moreover, phillyrin, as a promotor of PL was also found. The isomer of forsythiaside A and compound 6 need to be isolated and identified.

3. Materials and Methods

3.1. Materials

The following materials were acquired and used: Orlistat (Chongqing Pharscin Pharmaceutical Group Co., Ltd., Chongqing, China); carboxyl-terminated magnetic beads (10 mg/mL, 1 μm) (Allrun, Shanghai, China); F. suspensa leaves (Shanxi University campus, Taiyuan, China); PL, N-3-dimethylaminopropyl-N′-ethyl-carbodiimide HCl (EDC), N-hydroxysuccinimide (NHS), 2-(N-morpholino) ethanesulfonic acid (MES), Tween 20, Tris and glycine (Gly) (Solarbio, Beijing, China); p-nitrophenyl butyrate (pNPB), and p-nitrophenol (pNP) (Sigma-Aldrich, St. Louis, MO, USA); standard compounds, including chlorogenic acid, caffeic acid, forsythiaside A, rutin, hesperidin, and phillyrin (Must Bio-Technology Co., Ltd., Sichuan, China); HPLC-grade methanol and 96-well microtiter plates (Fisher Scientific, Shanghai, China). Other reagents were analytically pure. All solutions were prepared by ultra pure water.

3.2. Preparation of the Subfractions of F. suspensa Leaves

The leaves of F. suspensa (Thunb.) Vahl were collected in the campus of Shanxi University in July 2014 and identified by Prof. Liwei Zhang, Institute of Molecular Science, Shanxi University, Taiyuan 030006, China. A voucher specimen (no. SXTY-05337) had been deposited at the Herbarium of Institute of Molecular Science, Shanxi University, China. First, the dried leaf powder (300 g) was added to 3 L of 70% ethanol, reflux was extracted for 1 h, and then the hot extraction solution was filtered. The extraction and filtration process was repeated twice. Second, the filtrates were concentrated to 500 mL (note: there was some water in 500 mL of concentrated liquid; if it was dried, its weight was 99.29 g, and the yield was 33.09%). Third, petroleum ether and ethyl acetate was used for extraction sequentially (1:1, v/v, twice) from the cooled concentrated liquid. Fourth, ethanol and water were employed to dissolve the remaining mixture sequentially (1:10, v/v, once) (note: due to a long extraction time, repeated extraction, and hot filtration, the 70% ethanol extraction contained various substances that could not be completely dissolved in cold ethanol and could be divided into five parts: an easily soluble part in cold petroleum ether, an easily soluble part in cold ethyl acetate, a soluble part in cold ethanol, a soluble part in cold water, and a final water-insoluble part). Finally, the corresponding subfractions and the final water-insoluble substance were dried. The petroleum ether extraction, ethyl acetate extraction, ethanol-soluble substance, water-soluble substance, and the final water-insoluble substance yields were 4.46%, 9.13%, 15.04%, 2.43%, and 1.81%, respectively.

3.3. Determination of Enzyme Inhibitory Activity of All Subfractions

A PL solution (100 µL, 0.5 mg/mL) was placed in a 1.5 mL centrifuge tube, and 20 µL of sample solution was then added. A Tris–HCl buffer (pH 7.5) was added to 900 µL, mixed, and incubated for 15 min at 37 °C. A pNPB solution (100 µL, 10 mmol/L) was added to the solution, which was oscillated and then quickly transferred to a 96-well microtiter plate. Finally, the change rate K, which is the change of absorbance of the solution at 400 nm over 15 min, was measured with a microplate reader. The inhibition rate was calculated as follows:
Inhibition rate (%) = (K normal value − K experimental value)/K normal value × 100%.
In the reaction system, PL, pNPB, and DMSO were used as a normal group, PL, pNPB, and orlistat (DMSO solution) as a positive control group, and PL, pNPB, and inhibitor (DMSO solution) as an experimental group. K normal value = (pNP absorbance (after 15 min) − pNP absorbance (0 min))/15, namely the rate of enzyme reaction, in normal group at 400 nm, and K experimental value was the same, but in experimental group. pNP was the product of pNPB catalyzed by PL. 0 min meant the beginning of absorbance detection by Microplate Reader. Each experiment was repeated three times.
The inhibition rates of all subfractions on PL were measured at 1.5 mg/mL.

3.4. Screening of Inhibitors in the Subfraction with the Highest Inhibitory Activity

Synthesis, characterization, stability, specificity, and repeatability of immobilized pancreatic lipase were published in [14].
The subfraction with the highest inhibitory activity was used to screen the PL inhibitors. The process was similar to the validation of immobilized PL. A Thermo Scientific Hypersil Gold C18 column (4.6 mm × 250 mm, 5 μm) was used for HPLC separation and detection. The detection wavelength was 270 and 340 nm. The column temperature and flow rate were 25 °C and 0.8 mL/min, respectively. The mobile phase was composed of methanol (A) and 0.3% acetic acid solution (B). The gradient elution was set as follows: 0–8 min, 30–33% A; 8–24 min, 33–40% A; 24–39 min, 40–48% A; and 39–55 min, 48–64% A.

3.5. Identification of Screened-Out Compounds

Comparison with the HPLC chromatograms of a mixture of standard compounds: Suitable amounts of chlorogenic acid, caffeic acid, forsythiaside A, rutin, hesperidin, phillyrin, and forsythiaside standards were dissolved in methanol and detected according to the aforementioned chromatographic conditions.
LC-MS identification: The compounds that were not matched with HPLC chromatograms of a mixture of standard compounds were separated and tentatively identified by LC-MS.

3.6. Determination of Enzyme Inhibitory Activity and Competition Types of Screened-Out Compounds

The detection method of enzyme inhibitory activity was similar to a determination of enzyme inhibitory activity of all subfractions. The test method of competition types was that pNP standard solution with concentrations of 0.02, 0.05, 0.1, 0.2, 0.3, 0.4, and 0.5 mmol/L was precisely prepared. When the standard curve was drawn, a PL solution (0.5 mg/mL) and the inhibitor solution with concentrations close to IC50 were prepared. The solution with no inhibitor was regarded as the control group, and solutions with an addition of inhibitor was regarded as the experimental group. The enzyme reaction rates were determined when the substrate concentrations were 0.25, 0.50, 0.75, 1.00, and 1.25 mmol/L. The map was drawn by Lineweaver–Burk double reciprocal plot method.

4. Conclusions

Using the appropriate methods, more active ingredients can be simply and quickly screened out all at one time from a complex natural product system. In conclusion, F. suspensa leaves contain numerous inhibitors of pancreatic lipase. A potential use of this tea for weight loss remains to be shown in pharmacological studies.

Acknowledgments

This work was supported by the Key Technology Research of Traditional Chinese Medicine Modernization of Shanxi Province (Zhendong Special) (2014ZD0304).

Author Contributions

T.C. and L.Z. conceived and designed the experiments; Y.L. performed the experiments; T.C., Y.L. and L.Z. analyzed the data; T.C. and L.Z. contributed reagents/materials/analysis tools; T.C. wrote the paper.

Conflicts of Interest

The authors have declared no conflict of interest.

References

  1. Report of a WHO Consultation. Obesity: Preventing and Managing the Global Epidemic; World Health Organization: Geneva, Switzerland, 2000.
  2. Haslam, D.W.; James, W.P.T. Obesity. Lancet 2005, 366, 1197–1209. [Google Scholar] [PubMed]
  3. World Health Organization. Available online: http://www.who.int/mediacentre/factsheets/fs311/en/index.html (accessed on June 2016).
  4. Ezzati, M.; Lopez, A.D.; Rodgers, A.; Vander Hoorn, S.; Murray, C.J. Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002, 360, 1347–1360. [Google Scholar] [PubMed]
  5. U.S. Department of Health and Human Services. Available online: http://www.fda.gov/ (accessed on June 2016).
  6. Baretic, M. Targets for medical therapy in obesity. Digest. Dis. Sci. 2012, 30, 168–172. [Google Scholar]
  7. Derosa, G.; Maffioli, P. Anti-obesity drugs: A review about their effects and their safety. Expert Opin. Drug Saf. 2012, 11, 459–471. [Google Scholar] [PubMed]
  8. Yun, J.W. Possible anti-obesity therapeutics from nature—A review. Phytochemistry 2010, 71, 1625–1641. [Google Scholar] [PubMed]
  9. Roh, C.; Jung, U. Screening of crude plant extracts with anti-obesity activity. Int. J. Mol. Sci. 2012, 13, 1710–1719. [Google Scholar] [PubMed]
  10. Birari, R.B.; Bhutani, K.K. Pancreatic lipase inhibitors from natural sources: Unexplored potential. Drug Discov. Today 2007, 12, 879–889. [Google Scholar] [PubMed]
  11. De la Garza, A.L.; Milagro, F.I.; Boque, N.; Campion, J.; Martinez, J.A. Natural inhibitors of pancreatic lipase as new players in obesity treatment. Planta. Medica. 2011, 77, 773–785. [Google Scholar] [PubMed]
  12. Del Castillo-Santaella, T.; Maldonado-Valderrama, J.; Cabrerizo-Vilchez, M.A.; Rivadeneira-Ruiz, C.; Rondon-Rodriguez, D.; Galvez-Ruiz, M.J. Natural inhibitors of lipase: Examining lipolysis in a single droplet. J. Agric. Food Chem. 2015, 63, 10333–10340. [Google Scholar] [PubMed]
  13. Tao, Y.; Zhang, Y.F.; Cheng, Y.Y.; Wang, Y. Rapid screening and identification of α-glucosidase inhibitors from mulberry leaves using enzyme-immobilized magnetic beads coupled with HPLC/MS and NMR. Biomed. Chromatogr. 2013, 27, 148–155. [Google Scholar] [PubMed]
  14. Chen, T.-G.; Wei, Y.-R.; Zhang, L.-W. Screening and Identification of pancreatic lipase inhibitors in polygonum cuspidatum with enzyme-immobilized magnetic nanoparticles and LC-MS/MS. Nat. Prod. Res. Dev. 2017, 29, 198–205. [Google Scholar]
  15. Qu, H.H.; Zhang, Y.M.; Wang, Y. Antioxidant and antibacterial activity of two compounds (forsythiaside and forsythin) isolated from Forsythia suspensa. J. Pharm. Pharmacol. 2008, 60, 261–266. [Google Scholar] [PubMed]
  16. Zhang, G.G.; Song, S.J.; Ren, J.; Xu, S.X. A new compound from Forsythia suspensa (Thunb.) Vahl with antiviral effect on RSV. J. Herb. Pharmacol. 2002, 2, 35–40. [Google Scholar]
  17. Dai, S.J.; Ren, Y.; Shen, L.; Zhang, D.W. New alkaloids from Forsythia suspensa and their anti-inflammatory activities. Planta Med. 2009, 75, 375–377. [Google Scholar] [PubMed]
  18. Kang, W.Y.; Wang, J.M. In vitro antioxidant properties and in vivo lowering blood lipid of Forsythia suspense leaves. Med. Chem. Res. 2010, 19, 617–628. [Google Scholar]
  19. Yuda, N.; Tanaka, M.; Suzuki, M.; Asano, Y.; Ochi, H.; Iwatsuki, K. Polyphenols extracted from black tea (Camellia sinensis) residue by hot-compressed water and their inhibitory effect on pancreatic lipase in vitro. J. Food Sci. 2012, 77, H254–H261. [Google Scholar] [PubMed]
  20. Nakai, M.; Fukui, Y.; Asami, S.; Toyoda-Ono, Y.; Iwashita, T.; Shibata, H.; Mitsunaga, T.; Hashimoto, F.; Kiso, Y. Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. J. Agric. Food Chem. 2005, 53, 4593–4598. [Google Scholar] [PubMed]
  21. Wu, X.; He, W.; Yao, L.; Zhang, H.; Liu, Z.; Wang, W.; Ye, Y.; Cao, J. Characterization of binding interactions of (−)-epigallocatechin-3-gallate from green tea and lipase. J. Agric. Food Chem. 2013, 61, 8829–8835. [Google Scholar] [PubMed]
  22. Habtemariam, S. Antihyperlipidemic components of cassia auriculata aerial parts: Identification through in vitro studies. Phytother. Res. 2013, 27, 152–155. [Google Scholar]
  23. Narita, Y.; Iwai, K.; Fukunaga, T.; Nakagiri, O. Inhibitory activity of Chlorogenic acids in decaffeinated green coffee beans against porcine pancreas lipase and effect of a decaffeinated green coffee bean extract on an emulsion of olive oil. Biosci. Biotechnol. Biochem. 2012, 76, 2329–2331. [Google Scholar] [PubMed]
  24. Cai, S.B.; Wang, O.; Wang, M.Q.; He, J.F.; Wang, Y.; Zhang, D.; Zhou, F.; Ji, B.P. In vitro inhibitory effect on pancreatic lipase activity of subfractions from ethanol extracts of fermented Oats (Avena sativa L.) and synergistic effect of three phenolic acids. J. Agric. Food Chem. 2012, 60, 7245–7251. [Google Scholar] [PubMed]
  25. Kawaguchi, K.; Mizuno, T.; Aida, K.; Uchino, K. Hesperidin as an inhibitor of lipases from porcine pancreas and pseudomonas. Biosci. Biotechnol. Biochem. 1997, 61, 102–104. [Google Scholar] [PubMed]
Sample Availability: Samples of the compounds rutin, phillyrin, chlorogenic acid, caffeic acid, forsythiaside A, hesperidin, phillygenin are available from the authors.
Figure 1. HPLC chromatograms of remaining precipitate of F. suspensa leaves (A: 270 nm; B: 340 nm), solution of screened out compounds (C: 270 nm; D: 340 nm), and mixed standard substances (E: 270 nm); 7 standard substances were completely detected at 270 nm, so 340 nm was not done) (1: Rutin; 2: Phillyrin; 4: Chlorogenic acid; 5: Caffeic acid; 8: Forsythiaside A; 9: Hesperidin; 11: Phillygenin).
Figure 1. HPLC chromatograms of remaining precipitate of F. suspensa leaves (A: 270 nm; B: 340 nm), solution of screened out compounds (C: 270 nm; D: 340 nm), and mixed standard substances (E: 270 nm); 7 standard substances were completely detected at 270 nm, so 340 nm was not done) (1: Rutin; 2: Phillyrin; 4: Chlorogenic acid; 5: Caffeic acid; 8: Forsythiaside A; 9: Hesperidin; 11: Phillygenin).
Molecules 22 00795 g001aMolecules 22 00795 g001b
Figure 2. MS2 spectra (A) and fragmentation schemes (B) of Compounds 6, 7, and 10 of F. suspensa leaves. (6: Isomer of forsythiaside A; 7: Arctigenin; 10: Kaempferol-3-O-rutinose).
Figure 2. MS2 spectra (A) and fragmentation schemes (B) of Compounds 6, 7, and 10 of F. suspensa leaves. (6: Isomer of forsythiaside A; 7: Arctigenin; 10: Kaempferol-3-O-rutinose).
Molecules 22 00795 g002aMolecules 22 00795 g002bMolecules 22 00795 g002c
Figure 3. Tentative identified 8 PL ligands from F. suspensa leaves: Rutin (1); Phillyrin (2); Chlorogenic acid (4); Caffeic acid (5); Arctigenin (7); Forsythiaside A (8); Hesperidin (9); Kaempferol-3-O-rutinoside (10).
Figure 3. Tentative identified 8 PL ligands from F. suspensa leaves: Rutin (1); Phillyrin (2); Chlorogenic acid (4); Caffeic acid (5); Arctigenin (7); Forsythiaside A (8); Hesperidin (9); Kaempferol-3-O-rutinoside (10).
Molecules 22 00795 g003
Figure 4. Inhibitive effects of remaining precipitate, phillyrin (Compound 2), forsythioside A (Compound 8), and arctigenin (Compound 7) of F. suspensa leaves on pancreatic lipase.
Figure 4. Inhibitive effects of remaining precipitate, phillyrin (Compound 2), forsythioside A (Compound 8), and arctigenin (Compound 7) of F. suspensa leaves on pancreatic lipase.
Molecules 22 00795 g004
Figure 5. Standard curve of p-nitrophenol.
Figure 5. Standard curve of p-nitrophenol.
Molecules 22 00795 g005
Figure 6. Inhibitive modes of remaining precipitate and screened compounds on pancreatic lipase in F. suspensa leaves (remaining precipitate, Rutin (1), Phillyrin (2), Chlorogenic acid (4), Caffeic acid (5), Arctigenin (7), Forsythiaside A (8), Hesperidin (9), Kaempferol-3-O-rutinoside (10)).
Figure 6. Inhibitive modes of remaining precipitate and screened compounds on pancreatic lipase in F. suspensa leaves (remaining precipitate, Rutin (1), Phillyrin (2), Chlorogenic acid (4), Caffeic acid (5), Arctigenin (7), Forsythiaside A (8), Hesperidin (9), Kaempferol-3-O-rutinoside (10)).
Molecules 22 00795 g006
Table 1. Inhibitory ratio of subfractions of F. suspensa leaves on pancreatic lipase (n = 3).
Table 1. Inhibitory ratio of subfractions of F. suspensa leaves on pancreatic lipase (n = 3).
Subfractions (1500 μg/mL)Inhibitory Ratio
Crude extract39.28%
Acetic ether extract44.17%
Ethanol extract15.91%
Water extract50.21%
Remaining precipitate81.48%
Table 2. MS2 analysis of Compounds 6, 7, and 10 of F. suspensa leaves.
Table 2. MS2 analysis of Compounds 6, 7, and 10 of F. suspensa leaves.
Peak No.tR (min)UV (nm)MS (m/z)MS2 (m/z)Tentative Identification
69.986216,247,290,330624479, 471, 325, 309, 181, 163Isomer of forsythiaside A
715.682208,230,280372355, 337, 325, 284, 201, 189, 137Arctigenin
1026.716265,337594285, 255, 229, 227, Kaempferol-3-O-rutinose
Table 3. Nine pancreatic lipase ligands screened out from F. suspensa leaves (n = 3).
Table 3. Nine pancreatic lipase ligands screened out from F. suspensa leaves (n = 3).
No.CompoundsSpeciesIC50 (μg/mL)IC50 (μmol/L)Mechanisms
1Rutin [22]Flavonoids91 ± 3.66 *149 ± 6.0 *competitive inhibition
2PhillyrinLignanoidsPromotionPromotionpromotor
3Isomer of forsythiaside APhenethylolsNo testedNo testedpossible competitive inhibition
4Chlorogenic acid [23]Polyphenols1120 ± 40 *3150 ± 120 *uncompetitive inhibition
5Caffeic acid [24]Polyphenols251.2 ± 9.3 *1394 ± 52 *uncompetitive inhibition
7ArctigeninLignanoids793.4 ± 3.92129 ± 10.5uncompetitive inhibition
8Forsythiaside APhenethylols1346 ± 5.32155 ± 8.5competitive inhibition
9Hesperidin [25]Flavonoids32 *52.4 *competitive inhibition
10Kaempferol-3-O-rutinoside [22]Flavonoids1.7 ± 0.3 *2.9 ± 0.5 *noncompetitive inhibition
Note: “*” represented that the data came from references.

Share and Cite

MDPI and ACS Style

Chen, T.; Li, Y.; Zhang, L. Nine Different Chemical Species and Action Mechanisms of Pancreatic Lipase Ligands Screened Out from Forsythia suspensa Leaves All at One Time. Molecules 2017, 22, 795. https://doi.org/10.3390/molecules22050795

AMA Style

Chen T, Li Y, Zhang L. Nine Different Chemical Species and Action Mechanisms of Pancreatic Lipase Ligands Screened Out from Forsythia suspensa Leaves All at One Time. Molecules. 2017; 22(5):795. https://doi.org/10.3390/molecules22050795

Chicago/Turabian Style

Chen, Tinggui, Yayun Li, and Liwei Zhang. 2017. "Nine Different Chemical Species and Action Mechanisms of Pancreatic Lipase Ligands Screened Out from Forsythia suspensa Leaves All at One Time" Molecules 22, no. 5: 795. https://doi.org/10.3390/molecules22050795

Article Metrics

Back to TopTop